tiprankstipranks
Myriad Genetics (MYGN)
NASDAQ:MYGN
US Market
MYGN
Myriad Genetics
RESEARCH TOOLSreports
Want to see MYGN full AI Analyst Report?

Myriad Genetics (MYGN) Stock News & Sentiment

430 Followers
Myriad Genetics Bets on Growth Amid Profit Squeeze
Premium
Company Announcements
Myriad Genetics Bets on Growth Amid Profit Squeeze
17d ago
MYGN
MYGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MYGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
25d ago
MYGN
Myriad Genetics Earnings Call Highlights Growth Amid Headwinds
Premium
Company Announcements
Myriad Genetics Earnings Call Highlights Growth Amid Headwinds
3M ago
MYGN
Execution and Reimbursement Risks Undermine Myriad Genetics’ Growth Outlook, Justifying Sell Rating
Premium
Ratings
Execution and Reimbursement Risks Undermine Myriad Genetics’ Growth Outlook, Justifying Sell Rating
3M ago
MYGN
Balancing Emerging Growth Momentum and Ongoing Uncertainty: Justifying a Hold Amid Attractive Valuation
Premium
Ratings
Balancing Emerging Growth Momentum and Ongoing Uncertainty: Justifying a Hold Amid Attractive Valuation
3M ago
MYGN
Is MYGN a Buy, Before Earnings?
Premium
Pre-Earnings
Is MYGN a Buy, Before Earnings?
3M ago
MYGN
Myriad Genetics’ Earnings Call: Mixed Signals and Future Prospects
Premium
Company Announcements
Myriad Genetics’ Earnings Call: Mixed Signals and Future Prospects
7M ago
MYGN
More MYGN News >

MYGN News on the Web

STATE STREET CORP Reduces Stake in Myriad Genetics Inc
GuruFocus News
Bearish
3 of Wall Street’s Favorite Stocks with Open Questions
stockstory
Bearish
Insider Buying: Paul Bisaro Acquires Shares of Myriad Genetics Inc (MYGN)
GuruFocus News
Bullish
Top Myriad Genetics Insider Makes Bold New Move on Company Stock
TipRanks News
Neutral
Piper Sandler Sticks to Its Buy Rating for Myriad Genetics (MYGN)
TipRanks News
Neutral
Analysts Have Conflicting Sentiments on These Healthcare Companies: Collegium Pharmaceutical (COLL), Myriad Genetics (MYGN) and Mineralys Therapeutics, Inc. (MLYS)
TipRanks News
Bearish
Guggenheim Sticks to Their Hold Rating for Myriad Genetics (MYGN)
TipRanks News
Neutral
Myriad Genetics price target lowered to $6 from $7 at TD Cowen
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
MYGN
Sector Average
Media Buzz
This Week1 articles
Weekly Average3.5 articles
News Sentiment
This Week19%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MYGN’s Media Buzz Sentiment?
1 articles about MYGN were published this week. In an average week, 3.5 articles are published.
    What is MYGN’s weekly average amount of articles?
    In an average week, 3.5 articles about MYGN are published.
      What is MYGN’s News Sentiment?
      19% of articles about MYGN were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        TLSATiziana Life Sciences
        Showing the stocks with the most bullish news sentiment over the past week